Blood Donation Screening Tests: Complete Panel and Rationale

Standard Blood Donor Screening in the US (FDA/AABB)

Every unit undergoes mandatory testing before release.

Donor Eligibility Screening (Pre-Donation)

  • Health history questionnaire (risk behaviors, travel, medications).
  • Physical: Hb/Hct (fingerstick), BP, pulse, temperature.
  • Weight ≥110 lb (50 kg).

Laboratory Testing on Each Donation

Additional Tests (Not Universal)

  • Hemoglobin electrophoresis (sickle cell trait – donor info).
  • CBC (WBC, RBC, platelets, indices) – donor health, not recipient safety.
  • ALT (liver health surrogate).
  • CMV status (for immunocompromised recipients).
  • Hemoglobin S (sickle) – donor notification.

Pathogen Reduction Technologies

  • INTERCEPT (platelets/plasma), Mirasol (platelets/plasma/whole blood) – reduce residual risk.

Deferral & Notification

  • Reactive → confirmatory testing → donor notification, counseling, deferral registry.
  • Lookback/recall if recent donation from positive donor.

Blood Disorders - Related Articles

Health Sciences © https://www.222health.com

TestMethodPurpose
ABO/Rh typingAutomated agglutinationCompatibility for transfusion
Antibody screen (unexpected)Indirect antiglobulinDetect alloantibodies (Kell, Duffy, Kidd, etc.)
HIV-1/2 Ag/AbChemiluminescence (4th gen)Window ~18 days
HBV: HBsAg, anti-HBc, HBV DNANAT + serologyWindow ~21 days (DNA)
HCV: Ab + HCV RNANAT + serologyWindow ~7 days (RNA)
Syphilis (Treponema pallidum)Treponemal (EIA/CIA) + nontreponemal (RPR)Detect active/past
HTLV-I/II AbEIAEndemic areas, transfusion-associated
West Nile Virus RNANAT (seasonal/universal)Emerging threat
Zika Virus RNANAT (as needed)Outbreak-responsive
Babesia (endemic areas)Ab + PCRTransfusion-transmitted
Chagas (T. cruzi) AbEIARisk-based / universal